Press Releases

Press Releases
4-16-2019 Results from the EDCR IIa trial where Diamyd^® is given subcutaneously
4-11-2019 Immunological findings supporting intralymphatic treatment with Diamyd^® to be presented today at a diabetes meeting in Stockholm
3-27-2019 Quarterly Report II 18/19
3-26-2019 Diamyd Medical announces strategic activities for 2019 and 2020
3-8-2019 European Phase IIb trial in type 1 diabetes with the diabetes vaccine Diamyd^® close to being fully recruited
3-4-2019 A new publication supports Diamyd Medical’s patent rights around GABA
1-23-2019 Quarterly Report I 18/19

Share This Page

Annual Report